Three studies back Bionano's optical genome mapping in blood cancers

Go back to Three studies back Bionano's optical genome mapping in blood cancers
(NASDAQ: BNGO) Delayed: 1.13 -0.05 (4.24%)
Previous Close $1.18    52 Week High $ 
Open $1.18    52 Week Low $ 
Day High $1.18    P/E N/A 
Day Low $1.10    EPS $ 
Volume 251,891